Barclays cuts General Mills stock price target on volume concerns By Investing.com

Multiple sell-side firms cut price targets on General Mills—Barclays to $41 from $43, UBS to $35 from $40, TD Cowen to $37 from $45, Stifel to $44 from $50, RBC to $55 from $60, Piper Sandler to $45 from $53—while the stock trades at $37.34 near its 52-week low of $37.46 and is down ~33% over the past year. Cuts follow weaker-than-expected Q3 results, underperformance in organic sales and margins, a reported ~37% decline in EPS (Stifel noted EPS was $0.09 below estimate), and expectations for ongoing volume and profit pressure into fiscal 2027; Barclays forecasts neutral pricing and modest category volume decline in North American Retail. General Mills kept fiscal-year guidance, but removal of buyback assumptions and continued margin/volume headwinds suggest continued downside risk to the shares.

Analysis

The active variable here is demand elasticity rather than raw cost trends — if incremental price normalization removes the buffer for volumes, we should expect share shifts and promotional intensity to re-emerge over a 3–12 month window. Retailer behavior will matter: grocers can either amplify the hit to manufacturers by destocking and increasing private-label promotions, or mute it by protecting national brands; the former accelerates downside, the latter compresses margin but preserves shelf momentum.

Second-order winners are grocers and private-label suppliers that capture trade-downs and incremental shelf space (think national grocers and CPG co-packers), while losers are mid-sized branded portfolios with high fixed factory leverage and heavy category exposure. Supply-chain effects include short-term destocking that reduces supplier order flow (pressuring yum-to-yield cycles) and working-capital swings that make buyback-fueled EPS support harder for companies with weak free cash flow profiles.

Key catalysts to watch: retailer inventory prints and promotional cadence (weekly POS data), commodity cost trajectories (wheat/dairy in next 2–6 quarters), and management language around capital returns (dividend vs buyback prioritization). Tail risks include a sudden commodity spike from adverse weather or a faster-than-expected consumer pullback; conversely, accelerating deflation in input costs and stable retail support would reverse pressure within 6–9 months.

A contrarian angle: headline weakness may overstate persistent demand loss because brand equity and rationalized SKUs can re-concentrate volume into higher-margin SKUs within 9–18 months, capping downside. If management shifts more aggressively to mix-upgrade, cost-out and targeted promotions (rather than broad price cuts), equity upside could be asymmetric from current levels — but execution risk is high and timing uncertain.

Key Decisions for Investors

• Short GIS via a March 2027 bear-put spread (buy Mar-27 $35 put, sell Mar-27 $25 put). Thesis: capture continued downside if volume erosion and retailer destocking persist over the next 6–12 months. Risk/reward: limited max loss (net premium) vs material payoff if GIS < $25; monitor weekly POS and retailer inventory prints to trim.
• Relative-value pair: short GIS equity / long KR (Kroger) equal notional for 3–9 months to express trade-down into private label. Thesis: grocers gain share on value rotation while branded supplier volumes fall. Risk: macro recession could hurt both; hedge by size and maintain stop if KR underperforms by >10% vs GIS.
• Volatility/contrarian: buy Jan 2028 GIS call spread (buy $38 call / sell $48 call). Thesis: 9–18 month recovery play if commodity deflation and SKU rationalization lift margins. Risk/reward: defined premium vs multi-bagger return if sentiment normalizes and stock re-rates.
• Credit-long hedge: accumulate GIS senior paper (5-year maturity) for carry over 6–24 months and pair with a small equity short. Thesis: credit is slower to move than equity — collect yield if operational stress is equity-driven and not credit-impairing. Risk: adverse credit shock from operational miss; cap allocation to limit portfolio credit exposure to single-name concentration.